- Record: found
- Abstract: found
- Article: not found
Circulating FABP4 and FABP5 levels are differently linked to OSA severity and treatment.
Raquel Català
1 ,
Anna Cabré ,
Salvador Hernández-Flix ,
Raimón Ferré ,
Sandra Sangenís ,
Núria Plana ,
Anna Texidó ,
Lluís Masana
Dec 01 2013
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
To evaluate circulating adipocyte and epidermal fatty acid-binding protein (FABP4 and FABP5) concentrations in patients with obstructive sleep apnea (OSA), as well as the effects of continuous positive airway pressure (CPAP) treatment.